Inhibition of endoplasmic reticulum stress and oxidative stress by vitamin D in endothelial cells

Free Radical Biology and Medicine

Volumn 99, Issue , 2016, Pages 1-10

  Haas, Michael J ^a   Jafri, Mohammad ^a   Wehmeier, Kent R ^a   Onstead Haas, Luisa M ^a   Mooradian, Arshag D ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

1,25 dihydroxyvitamin D3; Cardiovascular disease; Endoplasmic reticulum stress; Endothelial cells

Indexed keywords

ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCITRIOL; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; HYDROETHIDINE; INITIATION FACTOR 2ALPHA; SECALCIFEROL; SEOCALCITOL; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; TUNICAMYCIN; VITAMIN D; X BOX BINDING PROTEIN 1; 25-HYDROXYVITAMIN D; ANTIOXIDANT; BIOLOGICAL MARKER; CALCITRIOL RECEPTOR; HEAT SHOCK PROTEIN; INITIATION FACTOR 2; MOLECULAR CHAPERONE GRP78; STRESS ACTIVATED PROTEIN KINASE; VDR PROTEIN, HUMAN; ZK 191784;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIUM CELL; ENZYME INHIBITION; FLUORESCENCE; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA SPLICING; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PHOSPHORYLATION;

24,25-DIHYDROXYVITAMIN D 3; ANTIOXIDANTS; BIOMARKERS; CALCITRIOL; CELL SURVIVAL; ENDOPLASMIC RETICULUM STRESS; EUKARYOTIC INITIATION FACTOR-2; GENE EXPRESSION; GLUCOSE; HEAT-SHOCK PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; PHOSPHORYLATION; RECEPTORS, CALCITRIOL; TUNICAMYCIN; VITAMIN D; X-BOX BINDING PROTEIN 1;

EID: 84979529844     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.07.020     Document Type: Article

References (38)

1. [1] Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., Dai, S., Ford, E.S., Fox, C.S., Franco, S., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics−2014 update: a report from the American Heart Association. Circulation 129 (2014), e28–e292.
2. [2] Pradeepa, R., Prabhakaran, D., Mohan, V., Emerging economies and diabetes and cardiovascular disease. Diabetes Technol. Ther. 14:Suppl. 1 (2012), S59–S67.
3. [3] Libby, P., The forgotten majority: unfinished business in cardiovascular risk reduction. J. Am. Coll. Cardiol. 46 (2005), 1225–1228.
4. [4] Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent, C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., Peto, R., Barnes, E.H., Keech, A., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials. Lancet 376 (2010), 1670–1681.
5. [5] Gouni-Berthold, I., Krone, W., Berthold, H.K., Vitamin D and cardiovascular disease. Curr. Vasc. Pharmacol. 7 (2009), 414–422.
6. [6] Artaza, J.N., Mehrotra, R., Norris, K.C., Vitamin D and the cardiovascular system. Clin. J. Am. Soc. Nephrol. 4 (2009), 1515–1522.
7. [7] Dobnig, H., Pilz, S., Scharnagl, H., Renner, W., Seelhorst, U., Wellnitz, B., Kinkeldei, J., Boehm, B.O., Weihrauch, G., Maerz, W., Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyviatmin D levels with all-cause mortality and cardiovascular mortality. Arch. Intern. Med. 168 (2008), 1340–1349.
8. 2 vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 120 (2009), 687–698.
9. [9] Riek, A.E., Oh, J., Sprague, J.E., Timpson, A., de las Ruentes, L., Bernal-Mizrachi, L., Schechtman, K.B., Bernal-Mizrachi, C., Vitamin D suppression of endoplasmic reticulum stress promotes an anti-atherogenic monocyte/macrophage phenotype in type 2 diabetic patients. J. Biol. Chem. 287 (2012), 38482–38494.
10. [10] Anderson, R., Brot, C., Mejborn, H., Molgaard, C., Skovgaard, L.T., Trole, E., Ovesen, L., Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur. J. Clin. Nutr. 63 (2009), 1150–1153.
11. 3 for 1 year. J. Intern. Med. 267 (2010), 462–472.
12. [12] Patricia, M.K., Kim, J.A., Harper, C.M., Shih, P.T., Berliner, J.A., Natarajan, R., Nadler, J.L., Hendrick, C.C., Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999), 2615–2622.
13. [13] Chettab, K., Zibara, K., Belaiba, S.-R., McGregor, J.L., Acute hyperglycemia induces changes in transcription levels of 4 major genes in human endothelial cells: macroarrays-based expression analysis. Thromb. Haemost. 87 (2002), 141–148.
14. [14] Sampson, M.L., Davies, I.R., Brown, J.C., Ivory, K., Hughes, D.A., Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 1187–1193.
15. 2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51 (2002), 198–203.
16. [16] Sheikh-Ali, M., Sultan, S., Alamir, A., Haas, M.J., Mooradian, A.D., Hyperglycemia-induced endoplasmic reticulum stress in endothelial cells. Nutrition 26 (2010), 1146–1150.
17. [17] Sheikh-Ali, M., Sultan, S., Alamir, A., Haas, M.J., Mooradian, A.D., Effects of antioxidants on glucose-induced oxidative stress and endoplasmic reticulum stress in endothelial cells. Diabetes Res. Clin. Pract. 87 (2010), 161–166.
18. [18] Haas, M.J., Raheja, P., Jaimungal, S., Sheikh-Ali, M., Mooradian, A.D., Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells. Free Radic. Biol. Med. 52 (2012), 2161–2167.
19. [19] Prosser, H.C., Tan, J.T., Patel, S., Dunn, L.L., Vanags, L.Z., Bao, S., Ng, M.K., Bursill, C.A., Multifunctional regulation of angiogenesis by high-density lipoproteins. Cardiovasc. Res. 101 (2014), 145–154.
20. [20] Su, Y., Regulation of endothelial nitric oxide synthase activity by protein-protein interaction. Curr. Pharm. Des. 20 (2014), 3514–3520.
21. [21] Toell, A., Gonzalez, M.M., Ruf, D., Steinmeyer, A., Ishizuka, S., Carlberg, C., Different molecular mechanisms of vitamin D3 receptor antagonists. Mol. Pharmacol. 59 (2001), 1478–1485.
22. [22] Hiramatsu, N., Kasai, A., Hayakawa, K., Yao, J., Kitamura, M., Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia. Nucleic Acids Res., 34, 2006, e93.
23. [23] Carter, W.O., Narayanan, P.K., Robinson, J.P., Intracellular hydrogen peroxide anion detection in endothelial cells. J. Leukoc. Biol. 55 (1994), 253–258.
24. [24] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
25. [25] Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970), 680–685.
26. [26] Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets. Proc. Natl. Acad. Sci. USA 76 (1979), 4350–4354.
27. [27] Chomczynski, P., Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987), 156–159.
28. [28] Asemi, Z., Samimi, M., Tabassi, Z., Shakeri, H., Esmaillzadeh, A., Vitamin D supplementation affects serum high-sensitivity C-reactive protein, insulin resistance, and biomarkers of oxidative stress in pregnant women. J. Nutr. 143 (2013), 1432–1438.
29. [29] Masszi, G., Benko, R., Csibi, N., Horvath, E.M., Tokes, A.M., Novak, A., Beres, N.J., Tarszabo, R., Buday, A., Repas, C., et al. Endothelial relaxation mechanisms and nitrative stress are partly restored by Vitamin D3 therapy in a rat model of polycystic ovary syndrome. Life Sci. 93 (2013), 133–138.
30. [30] Salum, E., Kals, J., Kampus, P., Salum, T., Zilmer, K., Aunapuu, M., Arend, A., Eha, J., Zilmer, M., Vitamin D reduces deposition of advanced glycation end-products in the aortic wall and systemic oxidative stress in diabetic rats. Diabetes Res. Clin. Pract. 100 (2013), 243–249.
31. [31] Nakai, K., Fujii, H., Kono, K., Goto, S., Kitazawa, R., Kitazawa, S., Hirata, M., Shinohara, M., Fukagawa, M., Nishi, S., Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats. Am. J. Hypertens. 27 (2014), 586–595.
32. [32] Uberti, F., Lattuada, D., Morsanuto, V., Nava, U., Bolis, G., Vacca, G., Squarzanti, D.F., Cisari, C., Molinari, C., Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways. J. Clin. Endocrinol. Metab. 99 (2014), 1367–1374.
33. [33] McDowell, W., Schwarz, R.T., Dissecting glycoprotein biosynthesis by the use of specific inhibitors. Biochimie 70 (1988), 1535–1549.
34. [34] Zou, C.G., Cao, X.Z., Zhao, Y.S., Gao, S.Y., Li, S.D., Liu, X.Y., Zhang, Y., Zhang, K.Q., The molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC12 neuronal cells: the protective effect of insulin-like growth factor I. Endocrinology 150 (2009), 277–285.
35. [35] Nishkawa, T., Edelstein, D., Du, X.L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M.A., Beebe, D., Oates, P.J., Hammes, H.-P., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000), 787–790.
36. [36] Bikle, D.D., Gee, E., Halloran, B., Haddad, J.G., Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J. Clin. Investig. 74 (1984), 1966–1971.
37. [37] Issa, L.L., Leong, G.M., Eisman, Molecular mechanisms of vitamin D receptor action. Inflamm. Res. 47 (1998), 451–475.
38. [38] Riek, A.E., Oh, J., Sprague, J.E., Timpson, A., de las Fuentes, L., Bernal-Mizrachi, L., Schechtman, K.B., Bernal-Mizrachi, C., Vitamin D suppression of endoplasmic reticulum stress promotes an antiatherogenic monocyte/macrophage phenotype in type 2 eiabetic patients. J. Biol. Chem. 287 (2012), 38482–38494.